Skip to main content

Table 2 Predicted effects of mutations in ETC subunits

From: Mitochondrial mutations and metabolic adaptation in pancreatic cancer

ETC subunit

PDCL

Mutation

Predicted effect

Complex I human residues (corresponding Thermus thermophilus residues)

ND5

TKCC-02

Frameshift

Part of ND5 loss, therefore no active complex I

 

TKCC-07

V132A (V119)

V sits at the end of TM4 and faces TM3, may slightly destabilise fold in this area.

 

TKCC-07

A415T (V409)

A sits on TM13, facing TMs 9 and 10, may de-stabilise fold in this area and/or make channel cavity leaky in this area.

 

TKCC-26-LO

D58N (F55)

D sits on the beta-sheet from the beta-H motif, may interfere with conformational coupling.

ND4

TKCC-07

M201T (L199)

M sits on key flexible helix 7 and faces the lipid or supernumerary subunit, may interfere with mechanics of TM7 and decrease NADH:Q oxidoreductase activity and/or proton pumping.

ND2

TKCC-07

G168S (A247)

Directly facing traverse helix HL from ND5, might decrease NADH:Q oxidoreductase activity (or proton pumping only) preventing full movement of HL.

 

TKCC-15-LO

W30S (L108)

W provides part of a seal between ND2 and ND4L, therefore mutation might make it somewhat leaky to protons.

ND6

TKCC-07

T156I (V142)

T is near key ND2 Glu34 (GluTM5), so the mutation may interfere with its pKa and so with proton pumping through ND2. Fold in this area will also be disturbed.

Complex III (bovine model 2FYU)

CytB subunit

TKCC-03

M316Δ

May interfere with fold at the junction with subunit 6.

 

TKCC-04

M376T

Leu in bovine- peripheral, but may interact with N-term helix from subunit 7.

 

TKCC-18-LO

E271K

E in bovine- close to heme (6 A, directly facing the edge), so may well interfere with its redox properties.

  1. TM transmembrane, ND NADH dehydrogenase subunit, CytB cytochrome B